Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Drugmakers to share neglected compounds with British academia
Yahoo/Reuters
Tue, 07/22/14 - 08:47 am
Tags:
UK, R&D, AstraZeneca, GSK, JNJ, Eli Lilly, Pfizer, Takeda, UCB Pharmaceuticals
Johnson & Johnson sets $5 billion share buyback
Marketwatch
Tue, 07/22/14 - 08:37 am
Tags:
JNJ, share repurchase
It’s a Good Time to Be a Drugmaker: Why J&J Is Beating Wall Street
Wall St Cheat Sheet
Sat, 07/19/14 - 08:54 am
Tags:
JNJ
J&J's new fixer turns consumer division back into a profit center
Fierce Pharma
Wed, 07/16/14 - 11:11 am
Tags:
JNJ, consumer health
[video] Turnaround: What Was Fixed at Johnson & Johnson?
Bloomberg
Tue, 07/15/14 - 11:45 am
Tags:
JNJ
J&J 2Q profit climbs 13 percent on new-drug sales
Yahoo/AP
Tue, 07/15/14 - 09:37 am
Tags:
JNJ, earnings
Johnson & Johnson Earnings Preview: Pharma Buisness To Remain Strong
Seeking Alpha
Sat, 07/12/14 - 10:35 am
Tags:
JNJ, earnings
Earnings Preview: Johnson & Johnson Q2 2014
Seeking Alpha
Thu, 07/10/14 - 03:24 pm
Tags:
earnings, JNJ
Is This Johnson & Johnson's Worst Nightmare?
Motley Fool
Tue, 07/8/14 - 04:07 pm
Tags:
JNJ, Zytiga, Medivation, Xtandi, Olysio, Gilead Sciences, Sovaldi
FDA reviewers assess uterine surgical method tied to rare cancer
Yahoo/Reuters
Tue, 07/8/14 - 10:30 am
Tags:
FDA, fibroids, Ethicon Biosurgery, JNJ, devices
J&J hands over $25M milestone for daratumumab progress
Fierce Biotech
Mon, 07/7/14 - 11:25 am
Tags:
JNJ, daratumumab, Genmab
A Primer On The Hepatitis C Market
Yahoo/Investors Business Daily
Fri, 07/4/14 - 11:53 am
Tags:
hepatitis C, Gilead, Sovaldi, Merck, Victrelis, Incivek, Vertex Pharmaceuticals, Olysio, JNJ, AbbVie, Indenix, Bristol-Myers Squibb
Johnson & Johnson Unit Whacks 400 Jobs as Part of Reorganization
WSJ Online
Wed, 07/2/14 - 11:50 am
Tags:
JNJ, layoffs, reorganization, devices, DePuy
Will GlaxoSmithKline plc Become A Bid Target?
Motley Fool
Tue, 06/24/14 - 09:09 am
Tags:
GSK, JNJ, Novartis, M&A
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Fierce Pharma
Mon, 06/23/14 - 12:53 pm
Tags:
Amgen, Epogen, anemia, Procrit, JNJ
Johnson & Johnson: Expect Dividend Growth To Accelerate In Next 2 Years
Seeking Alpha
Sun, 06/22/14 - 09:22 am
Tags:
JNJ
NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis
Fierce Pharma
Thu, 06/19/14 - 10:36 am
Tags:
NICE, Pradaxa, Xarelto, bloodthinners, Eliquis, Bayer, JNJ, Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim
Medtronic vs. Johnson & Johnson: Meet the Market's Biggest New Rivalry
Motley Fool
Wed, 06/18/14 - 05:46 pm
Tags:
Medtronic, JNJ, devices
Johnson & Johnson: A New Marketing Strategy Could Drive Growth
Seeking Alpha
Fri, 06/13/14 - 09:30 am
Tags:
JNJ, R&D
Glaxo’s ViiV Joins J&J’s Janssen to Develop Single-Pill HIV Drug
Bloomberg
Thu, 06/12/14 - 09:26 am
Tags:
GSK, ViiV, JNJ, Janssen, HIV

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.